Skip to main content

Table 2 Multivariate analysis of correlation between phosphorylation of transgelin-2 at S145 residue and clinicopathologocial factors

From: Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer

Variable

Odds Ratio (95%) CI

p value

Tumor Stage (III-IV)

1.983 (0.671–5.994)

0.215

Lymph Node Involvement (yes)

1.601 (0.535–4.672)

0.393

Tumor Size (≥2 cm)

3.153 (1.363–7.636)

0.009